Cognitive Control Functions for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how brain lesions affect cognitive control, the brain's management of goal-directed behaviors. Researchers aim to understand how damage in specific brain areas, particularly the thalamus, impacts actions and decision-making. Participants will undergo cognitive tests, brain scans (such as MRIs), and EEGs to track brain activity. Suitable candidates include healthy adults without metal implants or claustrophobia, as well as patients with brain lesions but no psychiatric disorders. As an unphased trial, this study offers participants the chance to contribute to foundational research that could lead to new insights into brain function and cognitive health.
What prior data suggests that these testing procedures are safe?
Research has shown that studying brain damage, particularly in the thalamus (a part of the brain that helps control movement and senses), can reveal its impact on thinking and decision-making. This is crucial for individuals recovering from a stroke.
In previous studies, researchers used MRI scans to examine how thalamus damage affects recovery. Some results suggested that this damage can lead to poor recovery outcomes, such as difficulties in regaining movement and thinking skills.
Regarding safety, the procedures in this study—cognitive tests, MRI, and EEG (a test that measures brain activity)—are non-invasive and widely used. These methods are common in many research and medical settings, and no major safety concerns have been reported. Participants usually handle them well.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how subcortical thalamic lesions affect cognitive control in stroke patients using various testing procedures like cognitive behavioral testing, EEG, and MRI. Unlike traditional treatments for stroke that mainly focus on physical rehabilitation and medication to improve blood flow or prevent further strokes, this approach aims to understand and potentially improve cognitive functions. By examining different brain activities and responses, this trial could lead to new strategies to enhance cognitive recovery, offering hope for improved quality of life for stroke survivors.
What evidence suggests that this study's methods are effective for understanding cognitive control in stroke patients?
Research has shown that damage to the thalamus, a part of the brain, can affect thinking skills like memory and language. For example, studies find that people who have had strokes in the thalamus often struggle more with remembering things they see and hear compared to those without such strokes. Other evidence suggests these individuals may also face difficulties with language and skills needed for planning and decision-making. Additionally, problems in the brain connections linked to the thalamus can cause both movement and thinking challenges. This trial will determine the effects of subcortical thalamic lesions using cognitive behavioral testing, EEG, and MRI. These findings help scientists understand how damage to the thalamus affects thinking and guide future research on recovery methods.56789
Are You a Good Fit for This Trial?
This trial is for adults who have had a stroke and are interested in how it may affect their cognitive control, such as the ability to adapt thoughts and actions based on goals. Participants will undergo tests like working memory and set-switching tasks, along with MRI scans and EEG studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Behavioral Testing
Participants perform cognitive tasks to assess their ability to monitor internal goals, maintain and manipulate information, and inhibit distractions.
EEG Procedures
EEG recordings are taken while participants perform tasks involving cognitive control, with eye movements passively recorded.
MRI Procedures
MRI scans are conducted to determine the location of brain structures, with participants screened for contraindications.
Follow-up
Participants are monitored for cognitive flexibility performance and reaction time to cognitive switching manipulation.
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kai Hwang
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator